WHO: Rehabilitation plasma therapy for neo-coronary pneumonia has not been proven to be effective or has led to a number of side effects.

On August 24th, local time, WHO held a regular press conference on neo-coronary pneumonia, in response to the United States authorized medical institutions can urgently use the plasma of new coronavirus infections for rehabilitation to treat new coronary inpatients, WHO Chief Scientist Sumia Swaminathan said that rehabilitation plasma therapy has been used for more than 100 years, has been used in different types of infectious diseases, some diseases effective but not effective for other diseases.
there have been several clinical trials worldwide for rehab plasma therapy for neo-coronary pneumonia, but only a few have published results with mixed results and no consistent conclusions, and the quality of evidence remains low.
, WHO recommends that rehabilitation plasma therapy continue to be clinically evaluated as an experimental therapy.
Swaminathan also points out that rehabilitation plasma therapy still has some challenges in practice, such as different levels of antibodies carried by people infected with new coronary pneumonia after rehabilitation, which are difficult to standardize.
addition, the number of hospitals that can implement the therapy, as well as the number of donors, is limited, but the most important question is whether the effectiveness and safety of the therapy can be confirmed in randomized trials.
Who who is a senior adviser to the Director-General of WHO, Bruce Elward, says plasma rehabilitation therapy has many side effects, from chills and fevers to more severe lung damage and even blood circulation overload, so clinical trial results are crucial.
()